s6y
Company name or ticker
Search
Nasus Pharma Ltd
4
Rubin Eyal: Statement of changes in beneficial ownership of securities
Filed
Monday, September 21, 2026
Period
Sep 18, 2026
Accession number
0001493152-26-043559
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header